Malawi | Imports and Exports | World | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Malawi totalled $ 5.13 thousand in 2023. Sales of commodity group 3002 from Malawi decreased by 26% in value terms compared to 2022. exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" decreased by $ 1.81 thousand (cumulative exports of commodity group 3002 from Malawi amounted $6.95 thousand in 2022)
Exports of commodity group 3002 amounted to 22% of total sales of group "" from Malawi in 2023 (the value of exports of commodity group from Malawi amounted to $22 thousand in 2023). The share of exports of commodity group 3002 in sales of commodity group from Malawi increased by 21 p.p. compared to 2022 (it was 0.806% in 2022, and exports of commodity group from Malawi were $861 thousand).
Where does Malawi export Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc?
Top export destinations of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Malawi in 2023:
- South Africa with a share of 89% (4.57 thousand US$)
- USA with a share of 6.95% (357 US$)
- Tanzania with a share of 1.59% (81 US$)
- Mozambique with a share of 1.3% (66 US$)
- United Kingdom - 21 US$
- Japan - 12.9 US$
- Uganda - 9.56 US$
- Netherlands - 8.82 US$
Exports structure of 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc - from Malawi in 2023 represented by the following main commodity groups:
- 11.2% (576 US$): 300290 - Human blood; animal blood prepared for therapeutic/prophylactic/diagnostic uses; toxins, cultures of micro-organisms (excl. yeasts) & sim. products
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to Malawi totalled $ 62 million in 2023. Sales of commodity group 3002 to Malawi went up by 104% compared to 2022: imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 31 million (the value of imports of commodity group 3002 to Malawi was equal to $30 million in 2022)
Imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" accounted for 1.97% of total import flow to Malawi (in 2023, total imports to Malawi amounted to $ 3.14 billion). The share of commodity group 3002 in total imports to Malawi increased by 0.067 p.p. compared to 2022 (it was 1.9% in 2022 and cumulative imports to Malawi were equal to $ 1.58 billion).
Imports of commodity group 3002 reached 36% of total imports of group "" to Malawi in 2023 (imports of commodity group to Malawi totalled $169 million in 2023). The share of purchases of commodity group 3002 in imports of commodity group to Malawi went down by 11.2 p.p. compared to 2022 (it was 48% in 2022, and imports of commodity group to Malawi accounted for $63 million).
Where does Malawi import Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc from?
Top trading partners (import of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc") of Malawi in 2023:
- Belgium with a share of 50% (31 million US$)
- India with a share of 29% (18.6 million US$)
- Netherlands with a share of 7.89% (4.89 million US$)
- Korea with a share of 5.01% (3.11 million US$)
- Denmark with a share of 1.36% (849 thousand US$)
- Hungary with a share of 1.04% (651 thousand US$)
- South Africa - 581 thousand US$
- USA - 572 thousand US$
- United Kingdom - 447 thousand US$
- Germany - 248 thousand US$
Imports structure of 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc - to Malawi in 2023 represented by the following main commodity groups:
- 0.448% (278 thousand US$): 300290 - Human blood; animal blood prepared for therapeutic/prophylactic/diagnostic uses; toxins, cultures of micro-organisms (excl. yeasts) & sim. products
